Review of the Treatment of Mycosis Fungoides and Sézary Syndrome: A Stage-Based Approach

Restricted access

The NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin's Disease were recently revised to include recommendations for treating mycosis fungoides and Sézary syndrome. These uncommon lymphomas require a specialized evaluation and use a unique TNMB staging system. Unlike the other forms of non-Hodgkin's lymphomas, stage overwhelmingly determines prognosis and defines radically different treatment approaches. For patients with early-stage disease, initial treatment with skin-directed therapies is preferred, and many patients never require systemic therapy. For patients with refractory or advanced-stage disease, biologic therapies are often the first choices, whereas chemotherapies are reserved for later in the disease course. Many milder therapies may be repeated several times in the disease course, and maintenance and tapering strategies are common. This article also discusses the emerging role of allogeneic stem cell transplantation.

Correspondence: Steven M. Horwitz, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021. E-mail: horwitzs@mskcc.org
  • 1.

    CriscioneVDWeinstockMA. Incidence of cutaneous T-cell lymphoma in the United States, 1973–2002. Arch Dermatol2007;143:854859.

  • 2.

    WillemzeRJaffeESBurgG. WHO-EORTC classification for cutaneous lymphomas. Blood2005;105:37683785.

  • 3.

    KimYHLiuHLMraz-GernhardS. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic risk factors for disease progression. Arch Dermatol2003;139:857866.

    • Search Google Scholar
    • Export Citation
  • 4.

    ZelenetzADAdvaniRHByrdJC. NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin's Lymphomas v. 1.2008. Last accessed: 14 February 2008.

    • Search Google Scholar
    • Export Citation
  • 5.

    OlsenEVonderheidEPimpinelliN. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood2007;110:17131722.

    • Search Google Scholar
    • Export Citation
  • 6.

    PimpinelliNOlsenEASantucciM. Defining early mycosis fungoides. J Am Acad Dermatol2005;53:10531063.

  • 7.

    VonderheidEBernengoMG. The Sezary syndrome: hematologic criteria. Hematol Oncol Clin N Amer2003;17:13671389.

  • 8.

    VonderheidECBernengoMGBurgC. Update on erythrodermic cutaneous T-cell lymphoma: report of the international society for cutaneous lymphomas. J Am Acad Dermatol2002;46:95106.

    • Search Google Scholar
    • Export Citation
  • 9.

    ZackheimHSAminSKashani-SabetMMcMillanA. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol1999;40:418425.

    • Search Google Scholar
    • Export Citation
  • 10.

    van DoornRVan HaselenCWvan Voorst VaderPC. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol2000;136:504510.

    • Search Google Scholar
    • Export Citation
  • 11.

    DiamandidouEColomeMFayadL. Prognostic factor analysis in mycosis fungoides/Sézary syndrome. J Am Acad Dermatol1999;40:914924.

  • 12.

    VergierBde MuretABeylot-BarryM. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood2000;95:22122218.

    • Search Google Scholar
    • Export Citation
  • 13.

    van DoornRSchefferEWillemzeR. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol2002;138:191198.

    • Search Google Scholar
    • Export Citation
  • 14.

    DiamandidouEColome-GrimmerMFayadL. Transformation of mycosis fungoides/Sézary syndrome: clinical characteristics and prognosis. Blood1998;92:11501159.

    • Search Google Scholar
    • Export Citation
  • 15.

    OlsenEAKimYHKuzelTM. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol2007;25:31093115.

    • Search Google Scholar
    • Export Citation
  • 16.

    OlsenEDuvicMFrankelA. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol2001;19:376388.

    • Search Google Scholar
    • Export Citation
  • 17.

    DuvicMHymesKHealdP. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol2001;19:24562471.

    • Search Google Scholar
    • Export Citation
  • 18.

    StrausDJDuvicMKuzelT. Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma. Cancer2007;109:17991803.

    • Search Google Scholar
    • Export Citation
  • 19.

    McGinnisKSJunkins-HopkinsJMCrawfordG. Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms. J Am Acad Dermatol2004;50:375379.

    • Search Google Scholar
    • Export Citation
  • 20.

    VonderheidECBiglerRDGreenbergAS. Extracorporeal photopheresis and recombinant interferon alfa 2b in Sézary syndrome. Use of dual marker labeling to monitor therapeutic response. Am J Clin Oncol1994;17:255263.

    • Search Google Scholar
    • Export Citation
  • 21.

    McGinnisKSUbrianiRNewtonS. The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome. Arch Dermatol2005;141:11761178.

    • Search Google Scholar
    • Export Citation
  • 22.

    GottliebSLWolfeJTFoxFE. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol1996;35:946957.

    • Search Google Scholar
    • Export Citation
  • 23.

    KayeFJBunnPAJrSteinbergSM. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med1989;321:17841790.

    • Search Google Scholar
    • Export Citation
  • 24.

    BunnPAJrFischmannABSchechterGP. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas. Cancer Treat Rep1979;63:713717.

    • Search Google Scholar
    • Export Citation
  • 25.

    WollinaUDummerRBrockmeyerNH. Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma. Cancer2003;98:9931001.

    • Search Google Scholar
    • Export Citation
  • 26.

    DuvicMTalpurRWenS. Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma. Clin Lymphoma Myeloma2006;7:5158.

  • 27.

    LundinJHagbergHReppR. Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome. Blood2003;101:42674272.

    • Search Google Scholar
    • Export Citation
  • 28.

    BernengoMGQuaglinoPComessattiA. Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. Haematologica2007;92:784794.

    • Search Google Scholar
    • Export Citation
  • 29.

    QuerfeldCRosenSTGuitartJ. Alemtuzumab (Campath-1H) in patients with erythrodermic cutaneous t-cell lymphoma (E-CTCL): the Northwestern University experience [abstract]. Blood2006;108: Abstract 2732.

    • Search Google Scholar
    • Export Citation
  • 30.

    MolinaAZainJArberDA. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. J Clin Oncol2005;23:61636171.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 271 271 63
PDF Downloads 113 113 24
EPUB Downloads 0 0 0